CANbridge Pharma Announces Board Reshuffle
Company Announcements

CANbridge Pharma Announces Board Reshuffle

CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.

CANbridge Pharmaceuticals Inc. has announced the resignation of Dr. Kan Chen as a non-executive Director and member of the audit committee, effective September 2, 2024. Dr. Chen’s departure is due to a desire to focus on personal commitments, with no reported disagreements or contentious issues related to his resignation. In his stead, Dr. Richard James Gregory will join the audit committee, as the company expresses gratitude to Dr. Chen for his service.

For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App